Skip to Main Content

Training Available: Spinal Muscular Atrophy (SMA)

Date: 10/16/20

Envolve Pharmacy Solutions (EPS) recently released educational material for providers regarding Spinal Muscular Atrophy (SMA).

SMA is a genetic disorder that starts in the central nervous system and affects all the muscles in the body. Due to the degenerative nature of the disease, people with SMA experience a decline in muscle strength over time, although the rate and severity can vary among individuals. Gene therapy options are now available for patients with SMA to help minimize the progression of the disease and improve survival.

Highlights from this training include:

  • Overview of Spinal Muscular Atrophy (SMA)
  • Explanation of the differences between SMA types
  • Discussion of the complications and impact of SMA
  • Review of current drug therapies approved for the treatment of SMA
     

Access the Spinal Muscular Atrophy Training (PDF)


This training was reviewed at the Q4 2020 meeting of the Louisiana Healthcare Connections Pharmacy and Therapeutics (P&T) Committee.